Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli:: Rescue of replication-competent virus progeny and packaging of amplicon vectors

被引:167
作者
Saeki, Y
Ichikawa, T
Saeki, A
Chiocca, EA
Tobler, K
Ackermann, M
Breakefield, XO
Fraefel, C [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg,Mol Neurooncol Lab, Charlestown, MA 02129 USA
[2] Northwestern Univ, BNBCB, Evanston, IL 60208 USA
[3] Univ Zurich, Inst Virol, CH-8057 Zurich, Switzerland
[4] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Mol Neurogenet Unit, Charlestown, MA 02129 USA
关键词
D O I
10.1089/hum.1998.9.18-2787
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Herpes simplex virus type 1 (HSV-1)-based amplicon vectors contain only similar to 1% of the 152-kb HSV-1 genome, and consequently, replication and packaging into virions depends on helper functions. These helper functions have been provided conventionally by a helper virus, usually a replication-defective mutant of HSV-1, or more recently, by a set of five cosmids that overlap and represent the genome of HSV-1 deleted for DNA cleavage/packaging signals (pac). In the absence of pac signals, potential HSV-1 genomes that are reconstituted from the cosmids via homologous recombination are not packageable, The resulting amplicon stocks are, therefore, virtually free of contaminating helper virus. To simplify this packing system, the HSV-1 genome was cloned and maintained stably as a single-copy, F plasmid-based bacterial artificial chromosome in E. coli. Such a plasmid containing the HSV-1 genome deleted for the pac signals (fHSV Delta pac) did not generate replication-competent progeny virus on transfection into mammalian cells, but rather, it was able to support the packaging of cotransfected amplicon DNA that contained a functional pac signal. The resulting amplicon vector stocks had titers of up to 10(7) transducing units per milliliter of culture medium and efficiently transduced neural cells in the rat brain, as well as hepatocytes in the rat. The capacity of generating infectious and replication-competent HSV-1 progeny following transfection into mammalian cells was restored after insertion of a pac signal into fHSV Delta pac.
引用
收藏
页码:2787 / 2794
页数:8
相关论文
共 22 条
[1]   Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo [J].
AboodyGuterman, KS ;
Pechan, PA ;
Rainov, NG ;
SenaEsteves, M ;
Jacobs, A ;
Snyder, EY ;
Wild, P ;
Schraner, E ;
Tobler, K ;
Breakefield, XO ;
Fraefel, C .
NEUROREPORT, 1997, 8 (17) :3801-3808
[2]  
BREAKEFIELD XO, 1995, INTERNET BOOK GENE T, P41
[3]   A COSMID-BASED SYSTEM FOR CONSTRUCTING MUTANTS OF HERPES-SIMPLEX VIRUS TYPE-1 [J].
CUNNINGHAM, C ;
DAVISON, AJ .
VIROLOGY, 1993, 197 (01) :116-124
[4]   Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors [J].
Fraefel, C ;
Jacoby, DR ;
Lage, C ;
Hilderbrand, H ;
Chou, JY ;
Alt, FW ;
Breakefield, XO ;
Majzoub, JA .
MOLECULAR MEDICINE, 1997, 3 (12) :813-825
[5]   Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells [J].
Fraefel, C ;
Song, S ;
Lim, F ;
Lang, P ;
Yu, L ;
Wang, YM ;
Wild, P ;
Geller, AI .
JOURNAL OF VIROLOGY, 1996, 70 (10) :7190-7197
[6]  
FRAEFEL C, 1998, GENE THERAPY NEUROLO, P63
[7]   AN EFFICIENT DELETION MUTANT PACKAGING SYSTEM FOR DEFECTIVE HERPES-SIMPLEX VIRUS VECTORS - POTENTIAL APPLICATIONS TO HUMAN GENE-THERAPY AND NEURONAL PHYSIOLOGY [J].
GELLER, AI ;
KEYOMARSI, K ;
BRYAN, J ;
PARDEE, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8950-8954
[8]   A DEFECTIVE HSV-1 VECTOR EXPRESSES ESCHERICHIA-COLI BETA-GALACTOSIDASE IN CULTURED PERIPHERAL NEURONS [J].
GELLER, AI ;
BREAKEFIELD, XO .
SCIENCE, 1988, 241 (4873) :1667-1669
[9]  
Glorioso Joseph C., 1995, P1, DOI 10.1016/B978-012397570-6/50003-4
[10]   HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells [J].
Johnston, KM ;
Jacoby, D ;
Pechan, PA ;
Fraefel, C ;
Borghesani, P ;
Schuback, D ;
Dunn, RJ ;
Smith, FI ;
Breakefield, XO .
HUMAN GENE THERAPY, 1997, 8 (03) :359-370